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Recreational use of synthetic cathinones, 3,4-methylenedioxypyrovalerone (MDPV)
and α‐pyrrolidinovalerophenone (α‐PVP), has become increasingly popular, thus prompting
characterization of their behavioral and neurochemical effects. MDPV has been studied for
several years now, though there is still much unknown about α‐PVP, and its isomers. The
primary objective of this study was to characterize the discriminative effects of α‐PVP and its
isomers in comparison to MDPV. Male and female Sprague-Dawley rats were trained to
discriminate 0.5mg/kg MDPV from saline injections under a fixed ratio 20 (FR 20) schedule of
food reinforcement. Substitution tests were conducted with MDPV (0.05-0.5mg/kg), α‐PVP
(0.05-0.5mg/kg), (S)-α‐PVP (0.05-1mg/kg) and (R)-α‐PVP (0.05-10mg/kg). All substances
produced a dose-dependent increase in MDPV-lever responses and dose response curves were
similar between males and females. Full substitution was observed in females at the highest dose
of all test compounds and all except (R)-α‐PVP in males. These results illustrate that α‐PVP, and
its isomers produce similar discriminative effects to those of MDPV with few
differences between males and females. Although the current findings add to the established
psychopharmacology of α‐PVP further investigations into its precise mechanisms of action are
critical to advancing medical treatments for substance abuse disorders involving this and related
synthetic cathinones.
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INTRODUCTION
Synthetic cathinones are a class of popular recreational “designer drugs” that became
prevalent in the early 2000’s. Cathinone is a naturally occurring amphetamine-like alkaloid
found in Catha edulis (khat), a native plant in the Middle East and Africa. The extracts in khat
leaves have been used for centuries for their psychostimulant effects, though a variety of
synthetic cathinones have been named and sold deceptively as “bath salts”, “plant fertilizer”,
“jewelry cleaner”, among many other names. Synthetic cathinone constituents mephedrone, 3,4methylenedioxypyrovalerone (MDPV), and methylone were permanently scheduled as Schedule
I drugs in 2012 and 2013 (Drug Enforcement Agency, 2014). Although these substances are now
Schedule I drugs, illicit use still remains a significant public health concern.
α‐pyrrolidinovalerophenone (α‐PVP) is another synthetic cathinone frequently used and
abused, commonly sold under the name “Flakka” or “gravel.” First synthesized in 1960, this
chemical does not have an extensive history of cultural use. More recently, α-PVP has become
an extremely popular “designer drug.” It gained popularity, particularly among recreational users
attempting to circumvent regulations of structurally related psychostimulants. Due to its high
potency and desired effects among recreational users, α-PVP is considered a dangerous drug,
reported to produce agitated delirium (Patocka et al., 2020). Agitated delirium is “characterized
by agitation, aggression, acute distress and sudden death” (Takeuchi, Ahern, and Henderson,
2011, p.77). Agitated delirium is sometimes caused by drugs that can also produce hypothermia,
cardiopulmonary arrest, and altered dopamine signaling. (Takeuchi, Ahern, & Henderson, 2011).
Psychopharmacological studies of α-PVP are limited and the effects of α-PVP on the central
nervous system (CNS) are still not understood. A few recent studies have examined the
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behavioral effects of α-PVP on spontaneous locomotor activity, conditioned place preference,
and conditioned taste avoidance with rats, self-administration and activity wheel running with
mice, and self-administration and drug discrimination in rhesus monkeys (Gianotti et al., 2017;
Nelson et al., 2017; Nelson et al., 2019; Nelson et al., 2019; Javadi-Paydar et al., 2018; Smith et
al., 2017; Collins et al., 2019). Only one of these studies examined α-PVP enantiomers in
comparison to the racemate. Additional pharmacological, pharmacogenetic, and
pharmacogenomic studies are ongoing to better characterize its behavioral and neurochemical
effects (Kolesnikova et al., 2019).
Drug discrimination is widely accepted preclinical behavioral assay commonly used to
compare novel chemicals to drugs with known neurochemical mechanisms related to their abuse
liability. MDPV and a variety of synthetic cathinones have been studied in this behavioral
paradigm for nearly a decade, though no published studies to date directly compared the
discriminative effects of MDPV and α-PVP. Stimulus substitution has been observed with other
psychostimulants in mice (Fantegrossi et al., 2013) or rats (Berquist et al., 2017; Risca & Baker,
2019) trained to discriminate MDPV. Conversely, MDPV substitutes in rats trained to
discriminate amphetamine (Harvey et al., 2017) or mice trained to discriminate cocaine (Gannon
et al., 2016). Additionally, α-PVP substituted in male rhesus monkeys trained to discriminate
cocaine (Smith et al., 2017) and rats trained to discriminate cocaine or methamphetamine (Gatch
et al., 2015; Naylor et al., 2015; Xu et al., 2021). Since MDPV and α-PVP are structurally and
pharmacologically similar and both substances exhibit comparable discriminative stimulus
effects to other psychostimulants, it was predicted that α-PVP will produce stimulus substitution
in rats trained to discriminate MDPV. With respect to predictive validity drug discrimination is
among the best behavioral paradigms to compare these substances.
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The majority of preclinical drug discrimination studies have nearly exclusively used male
subjects (Bevins, 2015), limiting the generalization of findings. When this study was initiated, no
published drug discrimination studies with MDPV or α-PVP included female subjects. Thus, a
secondary aim of the current study was to determine if α‐PVP substitution varies between males
and females. Though, few published studies have examined the effects of sex on the locomotor
stimulant effects and conditioned place preference with MDPV or α-PVP. (King et al., 2015;
Nelson et al., 2019; Risca et al., 2020). The results of those studies are reviewed and discussed in
comparison to the current findings in the discussion.

4

EXPERIMENTAL METHODS
Animal Subjects
Eight female Sprague-Dawley rats (Charles River, Inc. Wilmington, MA. USA)
weighing 250-300g and eight male Sprague-Dawley rats (Charles River, Inc. Wilmington, MA.
USA) weighing 480-510g were used in this study. The subjects were housed individually in
polycarbonate cages with corncob bedding (#7097; Envigo, Madison, Wisconsin, USA). The
animal facilities were kept at _50 ± 5% humidity and 20 ± 2°C under a 12:12 light/dark
cycle (7:00 –19:00). Commercial rodent diet (LabDiet 5001; PMI Nutrition Int. LLC,
Brentwood, Missouri, USA) was restricted to once per day feeding to maintain 85%-90% of free
feed weights, though the animals had free access to water in the home cage.
Apparatus
Training and testing were conducted in eight standard sound-attenuated operant
conditioning chambers equipped with three retractable levers (ENV-001; Med Associates Inc.,
St. Albans, Vermont, USA). Experiments were controlled with Med-PC software version IV.
Reinforcers presented during training sessions were 45mg Dustless Precision Pellets.
Drugs
3,4- methylenedioxypyrovalerone-hydrochloride (MDPV), α‐
pyrrolidinovalerophenone (α‐PVP), and isomers of α‐PVP, (S)-α‐PVP and (R)-α‐PVP were
provided by the National Institute of Drug Abuse Drug Control Supply (Bethesda, MD). All
compounds were dissolved in sterile 0.9% sodium chloride and injected intraperitoneally 15 min
prior to training or test sessions.
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Procedures
Preliminary training: Subjects were acclimated to the operant chambers for two 60minute sessions, once a day for two days. No levers were extended during these sessions and
food pellets were delivered under a fixed-time 60 s schedule. This procedure was to familiarize
the subjects to the location and sound of the pellet dispenser. Training sessions thereafter were
conducted 5-6 days a week and lasted 20 minutes per day. Subjects were initially trained to lever
press with the center lever extended; reinforcement was delivered under a fixed-ratio
(FR) schedule that was gradually increased from FR 1 to FR 20. Once
the subjects were reliably responding on the FR 20 schedule, errorless
training sessions commenced with either the right or left lever extended. Half of the
subjects were reinforced fore responses on the right lever following 0.5mg/kg MDPV injections
and for responses on the left lever following saline injections. Conditions were reversed for the
remaining subjects. Animals were injected 15 minutes prior to placement in the operant
conditioning chambers. A total of 12 errorless training sessions were conducted in the following
order: V, V, D, D, V, D, V, V, D, D, V, D (V=vehicle, D=drug, MDPV). Once schedule control
was established on both the drug-paired and vehicle-paired lever, discrimination training
started.
Discrimination training Discrimination training sessions lasted 20 minutes and
were conducted 5-6 days a week. During discrimination training sessions both right and left
levers were extended. Subjects were trained to discriminate 0.5mg/kg MDPV from vehicle on an
FR 20 schedule food reinforcement. Like in the preliminary training sessions, subjects’
responding was reinforced under a FR 1 schedule that was increased to a FR 20 schedule under
both drug and vehicle conditions, independently based on each subject’s performance. Drug and
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vehicle training sessions were alternated with sessions under the
same stimulus conditions occurring no more than two consecutive days. Performance criteria for
stimulus control was a minimum of eight out of ten consecutive discrimination training
sessions with an 80% or greater correct lever response prior to the delivery of the first
reinforcer and for the total session.
Stimulus substitution tests: Test sessions were similar to the discrimination sessions,
though the session ended with the completion of the first FR 20 or after 20 minutes, whichever
occurred first. No reinforcers were delivered during test sessions. Subjects were required to
complete at least one drug discrimination session and one vehicle discrimination session with
80% or higher responding between test sessions. Substitution tests were conducted with MDPV
(0-0.5mg/kg), α-PVP (0-0.5mg/kg), (S)-α-PVP (0-1mg/kg), and (R)-α-PVP (0-10mg/kg) in
subjects that continued to meet the aforementioned discrimination criteria. Each dose of each test
drug was counterbalanced among the subjects in both training groups.
Data Analysis
Discrimination accuracy with MDPV and substitution with the test compounds was
determined by calculating the percentage of responses on the MDPV-lever during substitution
tests. Response rate during substitution tests was expressed as responses per second and was
calculated by dividing the total number of responses emitted by the number of seconds required
to complete the test. Group means were calculated separately for males and females and plotted
in dose response curves for visual comparison. A nonlinear regression analysis was performed to
estimate the median effective dose (ED50) for each compound. Additionally, for each drug
assessed, a two-way repeated-measures (RM) analysis of variance (ANOVA) was conducted to
determine main effects of sex and dose and any sex by does interaction on the percentage of drug
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lever responses and on response rate. Substitution tests that yielded fewer than 10 responses were
considered incomplete and were excluded from statistical and graphic analyses. Animals that
failed to complete all test doses of a particular test compound were excluded from statistical
analyses, though data from all completed tests were included in the graphic analysis.
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RESULTS
This study evaluated stimulus substitution with α-PVP and its enantiomers in male and
female rats trained to discriminate MDPV from saline. Stimulus control was established in all
eight male and all eight female rats. Male rats met the initial discrimination criteria of 80%
correct responses for a minimum of eight out of 10 consecutive sessions within an average
of 29 (±3.45) training sessions (Range: 12-43). Seven of the eight female rats met the initial
discrimination criteria within an average of 30.4 (±3.6) training sessions (Range: 1641). Although training was suspended for 13 weeks due to unforeseen circumstances, all 16
subjects met these criteria again when training resumed. Including the initial sessions, prior to
the training hiatus, the average total number of sessions to meet the aforementioned criteria was
39.1 (±3.9) for males (Range: 25-53) and 48.6 (±3.3) for females (Range: 31-57). An unpaired ttest on the number of sessions to meet these criteria was not significantly significant between
males and females.
Dose response curves for MDPV are displayed in figure 1. MDPV produced a dosedependent increase in drug-lever responses and full substitution only at the training dose in both
males and females. The ED50 for MDPV was approximately 0.15mg/kg (95% confidence
interval (CI) [0.07 to 0.31 mg/kg]) for males and 0.12mg/kg (95% CI [0.06 to 0.24 mg/kg]) for
females. The graphic display of substitution test results includes all completed tests. However,
animals that did not complete the substitution tests with all MDPV doses were excluded from the
repeated measures two-way ANOVA. Six males and eight females were included in the RM
ANOVA of percent MDPV responses. This analysis revealed a statistically significant main
effect of dose (F (3, 36) = 15.7, P<0.01) on percent MDPV-lever responses. No statistically
significant differences were observed between sexes (F (1, 12) = 0.038, P=0.85) nor was there a
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statistically significant sex by dose interaction (F (3, 36) = 0.38, P=0.77). Statistical analysis of
response rate during MDPV substitution tests included all eight males and all eight females. The
main effect of dose (F (3, 42) = 1.65, P=0.19) and sex by dose interaction (F (3, 42) = 0.75,
P=0.53) were not statistically significant, though a statistically significant effect of sex was
observed on response rate (F (1, 14) = 6.29, P=0.03).
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Figure 1. MDPV Response Curves

As the study progressed, two female rats exhibited response disruption during MDPV
training sessions and their training dose was subsequently reduced. These animals were excluded
from group analysis of subsequent substitution tests. Dose response curves for α-PVP are
displayed in figure 2. These graphs show α-PVP produced a dose-dependent increase in MDPVlever responding, with complete substitution for MDPV at the highest dose of 0.5mg/kg. The
dose response curve of α-PVP is similar to that of MDPV with comparable
ED50. The ED50 was approximately 0.09 mg/kg (95% CI [0.04 to 0.20 mg/kg]) for male
rats and approximately 0.13 mg/kg (95% CI [0.06 to 0.32]) for female rats. The statistical
analysis for percentage MDPV-lever responses and response rate included eight males and six
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females. No statistical significance was found in percentage of MDPV-lever responses between
the sexes (F (1, 12) = 0.335, P=0.57) or in dose by sex interaction (F (3, 36) = 0.4217, P=0.74),
though there was statistically significance effect of α-PVP dose (F (3, 36) = 7.6,
P<0.01). Response rate displayed no significant differences between doses (F (3, 36) = 0.09,
P=0.97) or sex by dose interaction (F (3, 36) = 0.10, P=0.96). Response rate following α-PVP
treatment was significantly different between the sexes (F (1, 12) = 11.42, P=0.01).
o.-PVP

.,::

100

~

1.5

-+- MALES
-- FEMALES

C
0

"C

0

80

u
Cl)

~

...
VI

~

60

>
2i

40

VI

20

a.
Cl)

1.0

~

~

VI

Cl)

C:

::ii:'

c.,
.,~

-G· MALES

~ · FEMALES

C:

0

a::

IL

0.5

I+

L----· ··--...

f-----··r

0.01-'-----~-~-~-~

0

0 .05

0.1

0 .5

Dose (mg/kg)

0

0.05

0.1

0.5

Dose (mg/kg)

Figure 2. α -PVP Response Curves

The dose response curve for (R)-α-PVP is displayed in figure 3. The graph includes test
results from eight males and six females. Although a dose-dependent increase in drug-lever
responses was evident in both males and females, full substitution was observed only in females
at the highest dose tested (10mg/kg). The ED50 of (R)-α-PVP was approximately 2.69 mg/kg
(95% CI [1.01 to 6.74]) for females. The RM ANOVA of percent MDPV-lever responses
following tests with (R)-α-PVP includes eight male rats and six female rats. (R)-αPVP produced no statistically significant differences in MDPV-lever responses between the
sexes (F (1, 12) = 2.11, P=0.17) or in the sex by dose interaction (F (5, 60) = 0.79, P=0.56). A
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statistically significant dose effect was observed with (R)-α-PVP in percent MDPV-lever
responses (F (5, 60) = 7.1, P<0.01). Response rates following (R)-α-PVP treatment were not
significantly different between the sexes (F (1, 12) = 0.001, P=0.97) or among doses (F (5, 60) =
2.30, P=0.06), though a statistically significant sex by dose interaction was observed (F (5, 60) =
4.71, P<0.01)
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Figure 3. (R)-α -PVP Response Curves

The (S)-α-PVP dose response curve is displayed in figure 4. The graph includes test
results from eight males and six females. Full substitution for MDPV was observed following 0.5
and 1mg/kg. The ED50 was approximately 0.05mg/kg (95% CI [0.02 to 0.11]) for the
males and approximately 0.1 mg/kg (95% CI [0.05 to 0.18]) for the females. The results
from two males were excluded from the RM ANOVA following tests with (S)-α-PVP because
they failed to complete response requirement. Additionally, 1mg/kg (S)-α-PVP was excluded
from the two-way RM ANOVA tests because only three male rats completed the response
requirement following this dose; the other five males failed to respond after treatment with this
dose. Therefore, only six males and six females were included in the two-way RM ANOVA for
MDPV-lever responses with (S)-α-PVP substitution tests. This analysis, showed no statistically
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significant effect of sex (F (1, 10) = 0.80, P=0.39) or sex by dose interaction (F (3, 30) = 0.90,
P=0.45), although a statistically significant effect of dose was observed (F (3, 30) = 12.26,
P<0.01). Statistical analysis of the response rate included all eight males and six females.
This analysis showed no statistically significant effect of dose (F (4, 48) = 1.23, P=0.31), sex (F
(1, 12) = 0.18, P=0.68) or dose by sex interaction (F (4, 48) = 1.52, P=0.21).
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DISCUSSION
The present study examined the discriminative stimulus effects of αPVP and its isomers, (S)-α-PVP and (R)-α-PVP, in male and female rats trained
to discriminate MDPV from saline. The number of training sessions required to establish
stimulus control with MDPV were comparable between males and females in this study and
consistent with previous studies conducted with male rats (Risca et al., 2019) and female rats
(Thomas et al. unpublished findings) under similar conditions in the same laboratory setting.
The primary objectives of this study were to assess substitution of α-PVP and its
isomers for MDPV and determine if these effects were sex-dependent. As predicted, α-PVP and
its isomers substituted for MDPV. All three substances produced dose-dependent increases in
MDPV-lever responses and full substitution at the highest dose tested in most rats, with
the exception of (R)-α-PVP in males. Dose response curves for MDPV, α-PVP, and (S)-α-PVP
were nearly identical in males and females, indicating that these effects are not sex-dependent.
Interestingly, sex differences were observed in response rate following treatment with MDPV
and α-PVP. Sex differences in response rate were not observed with either α-PVP isomer. The
reason for this discrepancy is not clear. Whereas tests with the isomers were conducted later in
the study, it is possible these differences are an artifact of timing. Therefore, additional tests to
re-determine the dose effect curve with MDPV are ongoing.
Only a few published studies were found that assessed sex differences in the behavioral
effects of MDPV (King et al., 2015; Hambuchen et al., 2018; Risca et al., 2020). Although these
studies utilized different behavioral assessments from the present study, the results are worth
noting for comparison. King et al. (2015) evaluated male and female SD rats in an
assessment conditioned taste aversion and conditioned place preference with MDPV. Although
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no sex differences were observed in CPP induced by MDPV, females exhibited a weaker taste
avoidance than males (King et al., 2015). Consistent with those findings, Risca et al. (2020)
demonstrated minimal differences between male and female rats in MDPV-induced CPP, though
females displayed greater increases in activity following treatment with 1 or 3.2 mg/kg
MDPV. In an investigation of the pharmacokinetic profile of intravenous MDPV and its (R)- and
(S)-enantiomers, Hambuchen et al. (2018) also reported a statistically significant sex differences
in the locomotor effects following i.p. injections of MDPV in Sprague-Dawley rats, though they
found greater increases in horizontal activity following 3 mg/kg MDPV in males compared to
females. Additionally, they reported a higher magnitude and variance in bioavailability in males
compared to females. Considered together, these findings along with the current results indicate
MDPV produces differential effects in males and females in some behavioral measures and not
others.
Two published studies were found that assessed α-PVP in female rats. Jayadi-Paydar et
al., (2018) utilized female rats with activity wheel access to assess α-PVP self-administration and
binge-like behavior, and reported a binge-like initial acquisition and a decrease of value of
the wheel as a reinforcer. Nelson et al. (2019b) compared male and female Sprague-Dawley rats
in a study of α-PVP-induced taste avoidance, place preference, and locomotor activity. They
demonstrated that males exhibited a higher preference at lower α-PVP doses, while females only
exhibited CPP following treatments with 6mg/kg α-PVP. They
also reported females were slightly more sensitive to the locomotor effects of α-PVP and
displayed weaker taste avoidance (Nelson et al., 2019). These findings suggest that males may be
more susceptible to the rewarding and aversive effects of α-PVP.
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Nelson et al. (2019a) compared the α-PVP enantiomers in a conditioned taste avoidance
study with male rats. Both (S)-α-PVP and (RS)-α-PVP induced conditioned taste avoidance
whereas (R)-α-PVP failed to do so. Schindler et al. (2020) also conducted a study evaluating αPVP and its enantiomers in male rats, where they evaluated self-administration,
in vivo microdialysis, and telemetric assessment of cardiovascular parameters. They found
that all three substances block dopamine and norepinephrine transporters, but not serotonin
transporters. They also found that (S)- α-PVP increases dopamine in the nucleus accumbens as
well as locomotor activity. Increased elevation of blood pressure and heart rate were observed
with α-PVP and (S)- α-PVP with low doses, whereas these effects were observed with a
higher dose of (R)- α-PVP (6mg/kg). These findings demonstrate (S) α-PVP is approximately 30
times more potent than (R) α-PVP. This difference in potency is consistent with the current
finding that (S) α-PVP produced substitution for MDPV at lower doses than (R)- α-PVP.
Previous findings indicate the involvement of D1 dopamine in MDPV’s interoceptive
stimulus effects (Risca & Baker, 2019). In consideration of the present study results that αPVP substitutes fully for MDPV, it is likely that dopaminergic mechanisms also mediate the
discriminative stimulus effects of α-PVP. As noted above, Schindler et al. (2020) reported that αPVP and its isomers block dopamine and norepinephrine reuptake. To characterize the specific
involvement of dopaminergic and/or noradrenergic mechanisms contributing to α-PVP
discrimination, future investigations are required to assess the effects of selective dopamine
receptor antagonists in animals trained to discriminate α-PVP.
In conclusion, the current findings add to the psychopharmacology literature devoted to
characterizing the behavioral effects of novel drugs of abuse. Investigations
into the neurochemical mechanisms of novel drugs are crucial to medical advances in
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treating substance use disorders associated with synthetic cathinones. A variety of illicit “bath
salts” are frequently combined with other recreational drugs, and users may
not always be aware of the specific chemicals they consume. This contributes to the public health
problem associated with frequent abuse of these substances, specifically relevant to emergency
departments and law enforcement. Although hospital emergency department protocols may be in
place for treating individuals presenting with signs and symptoms of overdose with commonly
abused drugs, the psychopharmacology of a wide variety of new synthetic cathinones is still not
well understood. Further investigation into the neurochemical mechanisms underlying the
behavioral effects of popular synthetic cathinones can serve to inform medical management of
individuals seeking treatment for substance abuse or presenting in emergency departments with
adverse effects from their use.
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